| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,198 | 0,208 | 17:20 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | ARRAIL GROUP (06639): FURTHER DELAY IN PUBLICATION OF OUTSTANDING FINANCIAL RESULTS AND POSTPONEMENT OF ANNUAL GENERAL MEETING AND CONTINUED SUSPENSION ... | - | HKEx | ||
| 21.09. | ARRAIL GROUP (06639): REMUNERATION COMMITTEE - TERMS OF REFERENCE | - | HKEx | ||
| ARRAIL GROUP Aktie jetzt für 0€ handeln | |||||
| 01.09. | ARRAIL GROUP (06639): QUARTERLY UPDATE AND CONTINUED SUSPENSION OF TRADING | - | HKEx | ||
| 30.06. | ARRAIL GROUP (06639): INSIDE INFORMATION - (1) DELAY IN PUBLICATION OF THE ANNUAL RESULTS FOR THE YEAR ENDED MARCH 31, 2026 AND FURTHER DELAY IN PUBLICATION ... | - | HKEx | ||
| 01.06. | ARRAIL GROUP (06639): QUARTERLY UPDATE AND CONTINUED SUSPENSION OF TRADING | - | HKEx | ||
| 02.12.25 | XFRA I1D: AUSSETZUNG/SUSPENSION | 366 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME Waehrung/Currency ISIN BIS/UNTIL
ARRAIL... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 92,70 | +1,09 % | Medtronic: What Happens When Healthcare Technology Starts With People | From living rooms to operating rooms, human-centered design is informing the future of tech?Key takeawaysHuman-centered design at Medtronic uses patient, caregiver, and clinician insights to make medical... ► Artikel lesen | |
| HCA HEALTHCARE | 424,40 | +1,14 % | Nach der US-Wahl: Diese Aktien werden jetzt zu Gewinnern - deutsche Konzerne dabei | © Foto: wO-GeminiDer Wahlsieg der Demokraten verändert die Spielregeln an der Börse. Solaraktien schießen nach oben, auch Europas Industrie hofft auf Entlastung. Welche Unternehmen kurz- und langfristig... ► Artikel lesen | |
| LANTHEUS | 92,50 | -0,64 % | Lantheus Holdings, Inc.: Lantheus Presents Data from Two Pivotal Phase 3 Studies of TAUKLARIFY (Florquinitau F 18 Injection) PET Imaging in Early Alzheimer's Disease | ||
| CAREDX | 65,00 | -1,52 % | Biotech Stocks At 52-Week Highs - CareDx +13%, Grail Inc. +15%, Twist Bioscience +16%, Adaptive Biotechnologies, Revvity | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on September 24, 2026, driven by key catalysts such as reaching certain regulatory milestones or results from clinical... ► Artikel lesen | |
| ENVISTA | 21,400 | +0,94 % | Here's Why You Should Retain NVST Stock in Your Portfolio for Now | ||
| GT BIOPHARMA | 3,070 | -3,46 % | GT Biopharma reports Q3 results | ||
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results | Reports Record Fiscal Year Net Income of $2.8 Million, 14% YoY B2B ARR Increase and ARR of $22.5 Million
HENDERSON, Nev., Sept. 9, 2026 /PRNewswire/ -- Research... ► Artikel lesen | |
| CARMAT | - | - | CARMAT SAS: EFICAS Study Results Confirm the Clinical Performance of the Aeson Total Artificial Heart as a Bridge-to-Transplant Therapy | The study's primary endpoint was achieved in 72.7% of the 55 patients implanted between December 2022 and May 2025.
This rate was significantly above the historical benchmark of 38% established... ► Artikel lesen | |
| CHEMOMETEC | 92,00 | -0,97 % | ChemoMetec A/S: Significant growth in both revenue and earnings | ANNOUNCEMENT NR. 3255 November 2026 Trading statement for Q1 2026/27 (1 July - 30 September 2026) Significant growth in both revenue and earnings Revenue was up by 28% in Q1 2026/27 to DKK 160.0 million... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 5,630 | -0,53 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period July to September 2026 | "Our direct sales markets continued to grow in the third quarter. Over the period, we also took important steps to strengthen the business ahead of 2027. We broadened our product portfolio, launched... ► Artikel lesen | |
| PROMIMIC | 0,830 | +13,70 % | Promimic AB Q2 Sales Increase | ||
| FRESENIUS | 51,55 | -0,44 % | Fresenius gewinnt eine neue Wachstumsstory | Fresenius hat den schwierigen Teil seiner Neuaufstellung offenbar weitgehend hinter sich gelassen. Der Gesundheitskonzern steigert seine Profitabilität, reduziert die finanzielle Belastung und hebt... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,760 | +2,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,230 | -1,35 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Siemens Healthineers von "Outperform" auf "Market-Perform" abgestuft und das Kursziel von 44,50 auf 44 Euro gesenkt. Analystin... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,88 | -0,17 % | BMO raises BrightSpring Health stock price target on LDD momentum |